Association of serum kynurenine levels and neural networks in patients with first-episode, drug-naïve major depression: A source-based morphometry study

Naomichi Okamoto, Keita Watanabe, Lehoa Ngyuyen, Atsuko Ikenouchi, Taro Kishi, Nakao Iwata, Shingo Kakeda, Yukunori Korogi, Reiji Yoshimura

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The kynurenine (KYN) pathway can directly or indirectly influence cerebral volume and neural integrity in patients with major depression (MD). The aim of the present study was to investigate neural network systems and the KYN pathway in patients with first-episode, drug-naïve MD. Patients and Methods: Twenty right-handed drug-naïve patients, with MD diagnosed using the Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision, Research Version, were included in this study. Magnetic resonance imaging scans and scores on the Hamilton Rating Scale for Depression were assessed, and serum sampling was performed prior to the start of pharmacological treatment. Image processing and data analysis were performed according to our recently published procedure. Serum metabolomes were measured in the cation and anion modes of CE-FTMS-based metabolome analysis. Results: We found that serum KYN levels were positively correlated with the Z-scores of the salience network but not with those of the central executive network or default mode network. No associations were observed between serum glutamate levels and the Z-score of any of the three networks. Conclusion: Our results indicate that serum KYN levels might affect the activity of the salience network in first-episode, drug-naïve patients with MD.

Original languageEnglish
Pages (from-to)2569-2577
Number of pages9
JournalNeuropsychiatric Disease and Treatment
Volume16
DOIs
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Association of serum kynurenine levels and neural networks in patients with first-episode, drug-naïve major depression: A source-based morphometry study'. Together they form a unique fingerprint.

Cite this